# US 2019/0376964 A1 · Genetically encoded biosensors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376964 A1
- Document ID: US20190376964A1
- Status: Published application
- Kind: A1
- Application number: 16/002,697
- Filed: 2018-06-07
- Published: 2019-12-12
- Earliest claimed: 2011-10-07
- Assignees: Howard Hughes Medical Institute
- Applicants: Howard Hughes Medical Institute
- Inventors: Jonathan S. Marvin; Loren Looger
- Web page: https://patentgrep.com/patent/US20190376964A1

## CPC

- G01N 33/557: using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
- C07K 14/195: from bacteria
- C07K 14/245: Escherichia (G)
- C07K 14/43504: {from invertebrates}
- C07K 14/43595: {from coelenteratae, e.g. medusae}
- G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching
- G01N 33/582: {with fluorescent label}
- G01N 33/66: involving blood sugars, e.g. galactose
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- G01N 33/6812: {Assays for specific amino acids}
- C07K 2319/20: containing a tag with affinity for a non-protein ligand
- C07K 2319/24: containing a MBP (maltose binding protein)-tag
- C07K 2319/60: containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
- G01N 2400/00: Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N 2458/00: Labels used in chemical analysis of biological material
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present disclosure provides, inter alia, genetically encoded recombinant peptide biosensors comprising analyte-binding framework portions and signaling portions, wherein the signaling portions are present within the framework portions at sites or amino acid positions that undergo a conformational change upon interaction of the framework portion with an analyte.

## Claims

### Claim 1

A recombinant peptide biosensor comprising an analyte-binding framework portion and a signaling portion, wherein the signaling portion is present within the framework portion at a site or amino acid position that undergoes a conformational change upon interaction of the framework portion with a defined, specific, or selected analyte.

### Claim 2 (depends on 1)

The recombinant peptide biosensor of claim 1, wherein the signaling portion is allosterically regulated by the framework portion such that signaling from the signaling portion is altered upon interaction of the framework portion with the analyte.

### Claim 3 (depends on 1)

The recombinant peptide biosensor of claim 1, wherein signaling by the signaling portion detectably increases upon interaction of the framework portion with the analyte.

### Claim 4 (depends on 1)

The recombinant peptide biosensor of claim 1, wherein signaling by the signaling portion detectably decreases upon interaction of the framework portion with the analyte.

### Claim 5 (depends on 1)

The recombinant peptide biosensor of claim 1, wherein signaling by the signaling portion is proportional to the level of interaction between the framework portion and the analyte.

### Claim 6 (depends on 1)

The recombinant peptide biosensor of claim 1, wherein the framework portion has a first structure in the absence of an analyte and a second structure, that is detectably distinct from the first structure, in the presence of the analyte.

### Claim 7 (depends on 6)

The recombinant peptide biosensor of claim 6, wherein the conformational change between the first structure and the second structure allosterically regulates the signaling portion.

### Claim 8 (depends on 1)

The recombinant peptide biosensor of claim 1, wherein the framework portion is a periplasmic binding protein (PBP) or a variant of a PBP.

### Claim 9 (depends on 1)

The recombinant peptide biosensor of claim 1, wherein the signaling portion is a circularly permuted super fluorescent (SF) protein.

### Claim 10 (depends on 9)

The recombinant peptide biosensor of claim 9, wherein the SF protein is selected from the group consisting of a green fluorescent protein, a yellow fluorescent protein, a red fluorescent protein, and a blue fluorescent protein.

### Claim 11 (depends on 1)

The recombinant peptide biosensor of claim 1, wherein the analyte-binding framework portion binds specifically to an analyte selected from the group consisting of glucose, maltose, phosphonate, glutamate, GABA, and ACh.

### Claim 12

A recombinant peptide biosensor comprising an amino acid sequence with at least 90% identity to a recombinant peptide biosensor selected from the group consisting of SEQ ID NOs: 176-182, wherein the recombinant peptide biosensor binds specifically to glutamate.

### Claim 13 (depends on 12)

The recombinant peptide biosensor of claim 12, comprising a recombinant peptide biosensor selected from the group consisting of SEQ ID NOs: 176-182 comprising 10 or fewer conservative amino acid substitutions, wherein the recombinant peptide biosensor binds specifically to glutamate.

### Claim 14 (depends on 12)

The recombinant peptide biosensor of claim 12, comprising a recombinant peptide biosensor selected from the group consisting of SEQ ID NOs: 176-182.

### Claim 15

A recombinant peptide biosensor comprising an amino acid sequence with at least 90% identity to a recombinant peptide biosensor having the sequence shown in SEQ ID NO: 183, wherein the recombinant peptide biosensor binds specifically to glucose.

### Claim 16 (depends on 15)

The recombinant peptide biosensor of claim 15, comprising a recombinant peptide biosensor having the sequence shown in SEQ ID NO: 183 comprising 10 or fewer conservative amino acid substitutions, wherein the recombinant peptide biosensor binds specifically to glucose.

### Claim 17 (depends on 15)

The recombinant peptide biosensor of claim 15, comprising a recombinant peptide biosensor having the sequence shown in SEQ ID NO: 183.

### Claim 18

A recombinant peptide biosensor comprising an amino acid sequence with at least 90% identity to a recombinant peptide biosensor having the sequence shown in SEQ ID NO: 184, wherein the recombinant peptide biosensor binds specifically to GABA.

### Claim 19 (depends on 18)

The recombinant peptide biosensor of claim 18, comprising a recombinant peptide biosensor having the sequence shown in SEQ ID NO: 184 comprising 10 or fewer conservative amino acid substitutions, wherein the recombinant peptide biosensor binds specifically to GABA.

### Claim 20 (depends on 18)

The recombinant peptide biosensor of claim 18, comprising a recombinant peptide biosensor having the sequence shown in SEQ ID NO: 184.

### Claim 21

A recombinant peptide biosensor comprising an amino acid sequence with at least 90% identity to a recombinant peptide biosensor having a sequence selected from the group consisting of SEQ ID NO: 185 and 186, wherein the recombinant peptide biosensor binds specifically to ACh.

### Claim 22 (depends on 21)

The recombinant peptide biosensor of claim 21, comprising a recombinant peptide biosensor having a sequence selected from the group consisting of SEQ ID NO:
185 and 186 comprising 10 or fewer conservative amino acid substitutions, wherein the recombinant peptide biosensor binds specifically to ACh.

### Claim 23 (depends on 21)

The recombinant peptide biosensor of claim 21, comprising a recombinant peptide biosensor having a sequence selected from the group consisting of SEQ ID NO:
185 and 186.

### Claim 24 (depends on 1)

A nucleic acid encoding the recombinant peptide biosensor of claim 1.

### Claim 25 (depends on 24)

A vector comprising the nucleic acid of claim 24.

### Claim 26 (depends on 24)

A cell comprising the nucleic acid of claim 24.

### Claim 27 (depends on 25)

A cell comprising the vector of claim 25.

### Claim 28 (depends on 1, 24, 25, 26, 27)

A kit comprising the recombinant peptide biosensor of claim 1, the nucleic acid of claim 24, the vector of claim 25, the cell of claim 26, and/or the cell of claim 27.

### Claim 29

A method for detecting glutamate, the method comprising detecting a level of fluorescence emitted by a recombinant peptide biosensor, the peptide biosensor having an amino acid sequence selected from the group consisting of SEQ ID NOs: 176-182, and correlating the level of fluorescence with the presence of glutamate.

### Claim 30 (depends on 29)

The method of claim 29, wherein the recombinant peptide biosensor is expressed from a nucleic acid.

### Claim 31 (depends on 29)

The method of claim 29, comprising contacting the recombinant peptide biosensor with a sample comprising glutamate.

### Claim 32 (depends on 29)

The method of claim 29, comprising correlating the level of fluorescence with a concentration of glutamate.

### Claim 33 (depends on 32)

The method of claim 32, comprising comparing the level of fluorescence with a level of fluorescence emitted by the recombinant peptide biosensor in the presence of a sample comprising a known concentration or range of concentrations of glutamate.

### Claim 34 (depends on 29)

The method of claim 29, wherein the method is performed in vitro.

### Claim 35

A method for detecting glucose, the method comprising detecting a level of fluorescence emitted by a recombinant peptide biosensor, the peptide biosensor having an amino acid sequence shown in SEQ ID NO: 183, and correlating the level of fluorescence with the presence of glucose.

### Claim 36

A method for detecting GABA, the method comprising detecting a level of fluorescence emitted by a recombinant peptide biosensor, the peptide biosensor having an amino acid sequence shown in SEQ ID NO: 184, and correlating the level of fluorescence with the presence of GABA.

### Claim 37

A method for detecting ACh, the method comprising detecting a level of fluorescence emitted by a recombinant peptide biosensor, the peptide biosensor having an amino acid sequence selected from the group consisting of SEQ ID NOs: 185 and 186, and correlating the level of fluorescence with the presence of ACh.

### Claim 38 (depends on 1)

A method for detecting a defined, selected, or specific analyte, the method comprising detecting a level of fluorescence emitted by a recombinant peptide biosensor of claim 1; and correlating the level of fluorescence with the presence of a defined, selected, or specific analyte

### Claim 39 (depends on 38)

The method of claim 38, wherein the recombinant peptide biosensor is expressed from a nucleic acid.

### Claim 40 (depends on 38)

The method of any claim 38, comprising contacting the recombinant peptide biosensor with a sample comprising the analyte.

### Claim 41 (depends on 38)

The method of claim 38, comprising correlating the level of fluorescence with a concentration of the analyte.

### Claim 42 (depends on 41)

The method of claim 41, comprising comparing the level of fluorescence with a level of fluorescence emitted by the recombinant peptide biosensor in the presence of a sample comprising a known concentration or range of concentrations of the analyte.

### Claim 43 (depends on 38)

The method of claim 38, wherein the method is performed in vitro.

### Claim 44 (depends on 38)

The method of claim 38, wherein the analyte is selected from the group consisting of glutamate, glucose, GABA, and ACh.
